Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Gross Margin (2023 - 2025)

Historic Gross Margin for BioScience Health Innovations (BHIC) over the last 3 years, with Q3 2025 value amounting to 61.71%.

  • BioScience Health Innovations' Gross Margin fell 124200.0% to 61.71% in Q3 2025 from the same period last year, while for Sep 2025 it was 63.64%, marking a year-over-year decrease of 147800.0%. This contributed to the annual value of 70.94% for FY2024, which is 101200.0% down from last year.
  • Latest data reveals that BioScience Health Innovations reported Gross Margin of 61.71% as of Q3 2025, which was down 124200.0% from 61.14% recorded in Q2 2025.
  • In the past 5 years, BioScience Health Innovations' Gross Margin ranged from a high of 86.33% in Q2 2023 and a low of 55.56% during Q4 2024
  • Moreover, its 3-year median value for Gross Margin was 77.89% (2023), whereas its average is 74.9%.
  • Data for BioScience Health Innovations' Gross Margin shows a peak YoY increase of -7500bps (in 2024) and a maximum YoY decrease of -223400bps (in 2024) over the last 5 years.
  • Quarter analysis of 3 years shows BioScience Health Innovations' Gross Margin stood at 77.89% in 2023, then dropped by -29bps to 55.56% in 2024, then grew by 11bps to 61.71% in 2025.
  • Its last three reported values are 61.71% in Q3 2025, 61.14% for Q2 2025, and 73.03% during Q1 2025.